Guided Therapeutics Inc (GTHP)

[carbonfiltered]

VALUATION

Considering an O/S of 30 million and the Turkish deal being worth $12-18 million over 5 years, with a very low PE of 5 (should be 10) we arrive at a share price of .30-.45 factoring in expenses of 25% being that licensing fees and royalties carry no expenses. With a PE of 10 we arrive at .60-.90.... this is the REAL value of the Turkey deal.

We know the China deal is worth $47 million upon CFDA approval based on the signed contract so add $1.17.

India /USA is unknown at this point so let’s leave them out for now.

Considering a low PE of 5, the two contracts alone (one already approved by Turkish FDA, China pending), we have a share price value of $1.47-$1.62

This is assuming CFDA will approve, but considering SMI is already advertising on their website, and recently presented Luviva at a medical device convention in China, I’m not too concerned.